| Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma CK Rushton, SE Arthur, M Alcaide, M Cheung, A Jiang, KM Coyle, ... Blood advances 4 (13), 2886-2898, 2020 | 71 | 2020 |
| Natural killer cells induce neutrophil extracellular trap formation in venous thrombosis FR Bertin, RN Rys, C Mathieu, S Laurance, CA Lemarié, MD Blostein Journal of Thrombosis and Haemostasis 17 (2), 403-414, 2019 | 55 | 2019 |
| Gas6 Promotes Inflammatory (CCR2hiCX3CR1lo) Monocyte Recruitment in Venous Thrombosis S Laurance, FR Bertin, T Ebrahimian, Y Kassim, RN Rys, S Lehoux, ... Arteriosclerosis, thrombosis, and vascular biology 37 (7), 1315-1322, 2017 | 37 | 2017 |
| Apoptotic blocks in primary non-Hodgkin B cell lymphomas identified by BH3 profiling RN Rys, CM Wever, D Geoffrion, C Goncalves, A Ghassemian, ... Cancers 13 (5), 1002, 2021 | 11 | 2021 |
| Deep vein thrombosis induced by stasis in mice monitored by high frequency ultrasonography RN Rys, MD Blostein, CA Lemarié JoVE (Journal of Visualized Experiments), e57392, 2018 | 8 | 2018 |
| Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study EA Lasater, DN Amin, R Bannerji, RS Mali, K Barrett, RN Rys, J Oeh, ... American journal of hematology 98 (3), 449-463, 2023 | 7 | 2023 |
| A 10-color flow cytometry panel for diagnosis and minimal residual disease in chronic lymphocytic leukemia A Bazinet, RN Rys, A Barry, CMT Greenwood, YK Young, A Mendoza, ... Leukemia & Lymphoma 62 (10), 2352-2359, 2021 | 6 | 2021 |
| Successful pregnancy and fetal outcome following previous treatment with pembrolizumab for relapsed hodgkin's lymphoma A Le‐Nguyen, RN Rys, T Petrogiannis‐Haliotis, NA Johnson Cancer Reports 5 (1), e1432, 2022 | 5 | 2022 |
| Acquired resistance to EZH2 inhibitor GSK343 promotes the differentiation of human DLBCL cell lines toward an ABC-like phenotype SEJ Preston, A Emond, F Pettersson, D Dupéré-Richer, MJ Abraham, ... Molecular cancer therapeutics 21 (4), 511-521, 2022 | 4 | 2022 |
| EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax K Fooks, G Galicia-Vazquez, V Gife, A Schcolnik-Cabrera, Z Nouhi, ... Journal of Experimental & Clinical Cancer Research 41 (1), 340, 2022 | 3 | 2022 |
| Fas mutations in non-Hodgkin's lymphoma (NHL): implications for disease progression and therapeutic resistance RN Rys, M Venkataraman, J Zeng, KK Mann, N Johnson Blood 134, 1520, 2019 | 2 | 2019 |
| A 10-color flow cytometry panel for both diagnosis and minimal residual disease measurement in chronic lymphocytic leukemia A Bazinet, RN Rys, CM Wever, A Barry, C Greenwood, C Young, ... Blood 134, 5451, 2019 | 2 | 2019 |
| Primary Cutaneous Multifocal Indolent CD8+ T-Cell Lymphoma: a novel primary cutaneous CD8+ T-cell lymphoma T Petrogiannis-Haliotis, K Pehr, D Roberge, RN Rys, Y Monczak, ... Biomedicines 11 (2), 634, 2023 | 1 | 2023 |
| TLR3 promotes venous thrombosis through neutrophil recruitment M Najem, R Rys, S Laurance, F Couturaud, MD Blostein, CA Lemarié Revue des Maladies Respiratoires 38 (6), 580, 2021 | 1 | 2021 |
| Extracellular RNA induce neutrophil recruitment via endothelial TLR3 during venous thrombosis after vascular injury MY Najem, RN Rys, S Laurance, FR Bertin, V Gourdou-Latyszenok, ... bioRxiv, 2024.01. 18.576322, 2024 | | 2024 |
| mRNA Translation Inhibition Targets Bioenergetic Homeostasis in AML Cells in Vitro and In Vivo and Synergizes with Cytarabine and Venetoclax V Gife, K Fooks, J Berthelemy, A Schcolnik-Cabrera, G Galicia-Vazquez, ... Blood 142, 5742, 2023 | | 2023 |
| Early Identification of Refractory/Relapsed Diffuse Large B Cell Lymphoma with Serial Ctdna Sampling RN Rys, E Ritch, C Rushton, A Ahmed, E Brailovski, C Steidl, DW Scott, ... Blood 142, 2996, 2023 | | 2023 |
| Recurrent Copy Number Alterations Contribute to a Unique Genetic Landscape in Relapsed-Refractory DLBCL CK Rushton, RN Rys, E Chavez, LK Hilton, M Alcaide, K Dreval, ... Blood 140 (Supplement 1), 9259-9260, 2022 | | 2022 |
| Immune profiling of a patient with relapsed HIV-Related and EBV-positive diffuse large B-Cell lymphoma treated with pembrolizumab V Korsos, A Vallée, R Rys, S Probst, S Dmitrienko, H Decaluwe, ... Leukemia & Lymphoma 63 (5), 1256-1260, 2022 | | 2022 |
| The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma C Rushton, M Alcaide, M Cheung, NR Michaud, S Daigle, RN Rys, ... Blood 136, 8-9, 2020 | | 2020 |
